(1S,4R)-3-Dimethylcarbamoyl-7-oxa-bicyclo[2.2.1]hept-5-ene-2-carboxylatedimethyl-ammonium

ID: ALA368311

Chembl Id: CHEMBL368311

PubChem CID: 49796886

Max Phase: Preclinical

Molecular Formula: C12H20N2O4

Molecular Weight: 256.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)C(=O)C1C(C(=O)O)[C@@H]2C=C[C@H]1O2.CNC

Standard InChI:  InChI=1S/C10H13NO4.C2H7N/c1-11(2)9(12)7-5-3-4-6(15-5)8(7)10(13)14;1-3-2/h3-8H,1-2H3,(H,13,14);3H,1-2H3/t5-,6+,7?,8?;/m1./s1

Standard InChI Key:  FLYJFIAXXQEDPR-USEPEDARSA-N

Associated Targets(Human)

PPM1B Tchem Protein phosphatase 2C beta (71 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
G-401 (156 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 256.30Molecular Weight (Monoisotopic): 256.1423AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A..  (2004)  Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity.,  14  (8): [PMID:15050639] [10.1016/j.bmcl.2004.01.093]

Source